Get Live Data

focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Share Prices
  3. Faron Pharma Share Price
  4. Faron Pharma Share News
  5. UK Earnings, Trading Statements Calendar - Next 7 Days

Pin to quick picksFaron Pharma Share News (FARN)

Faron Pharma Information

Share Price Information for Faron Pharma (FARN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 238.00
Bid: 230.00
Ask: 246.00
Change: -27.00 (-10.19%)
Spread: 16.00 (6.957%)
Open: 265.00
High: 265.00
Low: 237.00
Prev. Close: 238.00
FARN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Tue, 01st May 2018 16:15

Wednesday 2 May 
Direct Line Insurance GroupQ1 Results
ConvaTec GroupQ1 Results
Sage GroupHalf Year Results
Standard CharteredQ1 Results (at 0515 BST)
Paddy Power BetfairQ1 Results
IndiviorQ1 Results
Howden Joinery GroupTrading Statement 
IWGTrading Statement 
InmarsatQ1 Results
Avon RubberHalf Year Results
Accsys TechnologyTrading Statement 
Thursday 3 May 
GlencoreQ1 Production
Elektron TechnologiesFull Year Results 
Equiniti GroupTrading Statement 
CentaminQ1 Results
James Fisher & SonsTrading Statement 
IMITrading Statement 
esure GroupQ1 Results
Lancashire HoldingsQ1 Results
Trinity MirrorTrading Statement 
Smith & NephewTrading Statement 
Apax Global AlphaQ1 Results
Wizz AirApril Traffic Statistics
Friday 4 May 
HSBC HoldingsQ1 Results (at 0500 BST)
International Consolidated Airlines GroupQ1 Results
InterContinental Hotels GroupQ1 Results
NumisHalf Year Results
Morgan SindallTrading Statement 
International Personal Finance Trading Statement 
Millennium & Copthorne HotelsQ1 Results
Smurfit Kappa GroupQ1 Results
Monday 7 May 
no events scheduled 
Tuesday 8 May 
William HillTrading Statement 
HiscoxTrading Statement 
Horizon Discovery GroupFull Year Results
Faron PharmaceuticalsFull Year Results
  

More News
8 Nov 2019 10:30

UK WINNERS & LOSERS SUMMARY: Games Workshop And Beazley Top FTSE 250

UK WINNERS & LOSERS SUMMARY: Games Workshop And Beazley Top FTSE 250

Read more
7 Nov 2019 17:59

Faron Pharmaceuticals Opens Private Placing To Fund Clevegen Progress

Faron Pharmaceuticals Opens Private Placing To Fund Clevegen Progress

Read more
1 Nov 2019 16:58

LONDON MARKET CLOSE: Upbeat Global Data Promotes Strong End To Week

LONDON MARKET CLOSE: Upbeat Global Data Promotes Strong End To Week

Read more
1 Nov 2019 15:32

Faron Pharmaceuticals Unable To Explain Significant Shares Price Surge

Faron Pharmaceuticals Unable To Explain Significant Shares Price Surge

Read more
9 Oct 2019 14:05

Faron Pharmaceuticals positive on feedback from 'Clevegen' monitoring committee

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced feedback from the 'MATINS' study data monitoring committee on Wednesday, from the ongoing dose escalation study from part 1 of the MATINS trial.

Read more
9 Oct 2019 09:18

Faron Pharmaceuticals To Test New Lower Dose In Clevegen Study

Faron Pharmaceuticals To Test New Lower Dose In Clevegen Study

Read more
2 Oct 2019 14:57

Faron Pharmaceuticals hits bump in road for Traumakine manufacturing

(Sharecast News) - Clinical-stage biopharmaceutical company Faron Pharmaceuticals announced on Wednesday that, further to its update in its interim results in relation to the active pharmaceutical ingredient (API) manufacturing process for 'Traumakine', Rentschler Biopharma has sent Faron a letter in which it terminated the agreement concerning the API manufacturing.

Read more
2 Oct 2019 13:13

Manufacturer Ends Traumakine Agreement With Faron Pharmaceuticals

Manufacturer Ends Traumakine Agreement With Faron Pharmaceuticals

Read more
23 Sep 2019 11:37

Faron Pharmaceuticals Ends Traumakine Trial; Loss Narrows On Expenses

(Alliance News) - Faron Pharmaceuticals Oy on Monday said its loss narrowed considerably in the first half of 2019, after it cut back on research & development spending and opted to end a firm

Read more
16 Sep 2019 15:59

UK Earnings, Trading Statements Calendar - Next 7 Days

Tuesday 17 September JTCHalf Year ResultsStafflineHalf Year GroupHalf Year Year

Read more
27 Aug 2019 16:34

Faron Pharma raises ?2.3m to keep it going through the start of 2020

(Sharecast News) - Clinical stage biopharmaceutical company Faron Pharmaceuticals has received valid acceptances and excess applications from qualifying shareholders for a total of 859,513 open offer shares, raising gross proceeds of around €1.01m (£0.92m) at the issue price of 106p per share and at the euro issue price of 119 cents per share, it announced on Tuesday.

Read more
27 Aug 2019 11:38

Faron Pharma Raises EUR2.5 Million; Now Has Working Capital To 2020

(Alliance News) - Faron Pharmaceuticals Oy on Tuesday said it has raised EUR2.5 million via share subscription and open offer.The company raised EUR1.0 million from the issue of 859,513 at

Read more
5 Aug 2019 12:26

Faron Pharmaceuticals To Raise EUR2.1 Million For Clevegen Development

(Alliance News) - Faron Pharmaceuticals Oy on Monday announced a EUR1.1 million subscription and EUR2.0 million open offer to fund the clinical development of cancer drug Clevegen.Shares in

Read more
12 Jul 2019 10:35

WINNERS & LOSERS SUMMARY: Thomas Cook Plunges On Rescue Deal Talks

(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Friday.----------FTSE 100 - WINNERS----------BHP up 1.5%. The -

Read more
12 Jul 2019 10:20

Faron Pharma Pleased By MATINS Progress And Plans To Increase Capacity

(Alliance News) - Faron Pharmaceuticals Oy said on Friday its MATINS study of nine cancer patients is progressing well, and it is planning to expand the clinical trial to more countries.The

Read more
6789101112131415

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.